```html

Sudden Sensorineural Hearing Loss (SSNHL)

Overview

Sudden sensorineural hearing loss (SSNHL) is defined as a rapid loss of hearing—usually ≥30 dB—in at least three contiguous frequencies occurring within a 72‑hour period. The loss is “sensorineural,” meaning it originates from damage to the inner ear (cochlea) or the auditory nerve, rather than the outer or middle ear.

Who it affects: Although SSNHL can occur at any age, it most commonly presents in adults between 30 and 60 years old. Men are slightly more likely to be affected than women (approximately 55 % vs. 45 %).

Prevalence: The condition is relatively rare, with an estimated incidence of 5–20 cases per 100,000 people per year worldwide. In the United States, roughly 10,000–15,000 new cases are reported annually.[1] Mayo Clinic, 2023

Symptoms

Symptoms often appear abruptly and may be unilateral (one ear) or, rarely, bilateral. The following list includes the most common and less‑common manifestations:

• Rapid hearing loss – a noticeable “plugged” feeling or muffled sounds in the affected ear.
• Tinnitus – ringing, buzzing, or hissing noises that may be constant or intermittent.
• Fullness or pressure sensation within the ear, similar to the feeling after a flight.
• Dizziness or vertigo – especially when the vestibular (balance) part of the inner ear is involved.
• Balance problems – unsteady gait or a sensation of “floating.”
• Ear pain – uncommon but may occur if an underlying infection is present.
• Facial nerve weakness – very rare, suggests a more extensive cranial neuropathy.

Causes and Risk Factors

The exact cause of SSNHL is often unknown (idiopathic), accounting for roughly 70 % of cases. The remaining cases are linked to several identifiable triggers:

Viral infections

Influenza, herpes simplex, varicella‑zoster, and cytomegalovirus can damage cochlear hair cells or the auditory nerve.[2] CDC, 2024

Vascular events

Sudden interruption of blood flow to the inner ear (e.g., micro‑thrombosis, emboli) can cause ischemic injury.

Autoimmune inner ear disease

Inflammatory antibodies attack inner‑ear structures, leading to rapid hearing loss.

Trauma

Acoustic trauma (e.g., a sudden loud explosion) or head injury can precipitate SSNHL.

Ototoxic medications

High‑dose aspirin, loop diuretics, certain chemotherapy agents (cisplatin), and some antibiotics (e.g., aminoglycosides) may damage the cochlea.

Neurological disorders

Multiple sclerosis or vestibular schwannoma (acoustic neuroma) can present with sudden hearing loss.

Other risk factors

• Upper‑respiratory tract infection within the past week.
• Recent exposure to loud noise.
• Smoking (increases vascular risk).
• Hypertension, diabetes, hyperlipidemia.
• Pregnancy (rare, linked to hormonal and vascular changes).

Diagnosis

Timely diagnosis is critical because treatment is most effective when started within the first two weeks.

Clinical evaluation

• History – onset, associated symptoms, recent infections, medication use, noise exposure.
• Physical examination – otoscopic inspection to rule out conductive causes; neurological exam for vestibular signs.

Audiologic testing

• Pure‑tone audiometry – the gold‑standard test; confirms ≥30 dB loss across three consecutive frequencies.
• Speech‑recognition testing – assesses functional hearing ability.
• Tympanometry – ensures middle‑ear function is normal.

Imaging

• Magnetic resonance imaging (MRI) with gadolinium – recommended to exclude acoustic neuroma, demyelinating disease, or vascular lesions. Sensitivity >95 % for inner‑ear pathology.
• CT scan – rarely needed, mainly if bone pathology or facial nerve involvement is suspected.

Laboratory studies (select cases)

• Complete blood count, fasting glucose, lipid panel – screen for systemic vascular risk.
• Serologic tests for syphilis, Lyme disease, autoimmune markers (ANA, RF) if indicated.

Treatment Options

Therapy aims to restore hearing, reduce inflammation, and prevent permanent damage. The earlier the intervention, the better the outcomes.

Corticosteroids (first‑line)

• Systemic oral prednisone – 1 mg/kg/day (max 60 mg) for 7–14 days, followed by a taper. Shown to improve hearing in 45‑65 % of idiopathic cases.[3] NIH, 2022
• Intratympanic steroid injection – dexamethasone or methylprednisolone placed directly onto the round window membrane. Useful when oral steroids are contraindicated or as a rescue after oral therapy fails.

Antiviral therapy

Empiric antivirals (e.g., acyclovir) are sometimes added when viral etiology is suspected, though evidence of benefit is limited.[4] JAMA Otolaryngology, 2021

Hyperbaric oxygen therapy (HBOT)

Patients receive 100% oxygen at 2–2.5 ATA for 60–90 minutes daily, usually 10–20 sessions. Meta‑analyses suggest modest benefit, especially when combined with steroids.[5] Cochrane Review, 2023

Other pharmacologic agents

• Vasodilators (e.g., pentoxifylline) – limited evidence.
• Anticoagulants/antiplatelet agents – considered only if a clear thrombotic cause is identified.

Rehabilitation

• Hearing aids – fitting once stable hearing thresholds are established (usually 4–6 weeks after onset).
• Cochlear implants – indicated for severe/profound loss not amenable to conventional amplification.

Lifestyle and supportive measures

• Rest and stress reduction – high cortisol may impair inner‑ear recovery.
• Smoking cessation – improves microvascular circulation.
• Close follow‑up with an otolaryngologist (ENT) and audiologist.

Living with Sudden Sensorineural Hearing Loss

Adapting to sudden changes in hearing can be challenging. Below are practical strategies to help maintain quality of life while treatment progresses.

Communication tips

• Position yourself face‑to‑face; visual cues (lip‑reading, facial expressions) become crucial.
• Ask conversational partners to speak clearly, not shout, and to pause between sentences.
• Use assistive listening devices (personal amplifiers, Bluetooth‑enabled hearing aids).

Home environment adjustments

• Reduce background noise—turn off TVs/radio when talking, use rugs or curtains to dampen echo.
• Install visual alerts (flashing lights) for doorbells, phone calls, or smoke alarms.
• Consider captioned telephone services or texting for important calls.

Workplace accommodations

• Request a quiet workspace or use noise‑cancelling headphones with a microphone.
• Utilize speech‑to‑text software for meetings.
• Notify HR about your condition; under the Americans with Disabilities Act (ADA), reasonable accommodations are required.

Emotional well‑being

• Sudden hearing loss can trigger anxiety or depression; counseling or support groups (e.g., Hearing Loss Association of America) are beneficial.
• Mind‑body practices—yoga, meditation—help manage stress, which may improve vascular health.

Follow‑up schedule

Typical follow‑up includes audiometry at 1 week, 1 month, and 3 months after treatment onset. Ongoing monitoring is essential to determine whether amplification or implant candidacy should be explored.

Prevention

Because many cases are idiopathic, absolute prevention is impossible. However, risk‑reduction measures can lower the likelihood of a vascular or inflammatory trigger:

• Control cardiovascular risk factors—maintain blood pressure < 130/80 mmHg, keep HbA1c < 7 % for diabetics, achieve LDL < 100 mg/dL.
• Avoid ototoxic medications when alternatives exist; if they are necessary, monitor hearing with baseline and periodic audiograms.
• Protect ears from sudden loud noises—use earplugs at concerts, while operating machinery, or during hunting.
• Stay up to date on vaccinations (influenza, COVID‑19, shingles) to reduce viral triggers.
• Quit smoking and limit alcohol—both impair microcirculation.
• Prompt treatment of upper‑respiratory infections—consider antiviral or antibacterial therapy only when medically indicated.

Complications

If left untreated or if treatment fails, SSNHL can lead to several adverse outcomes:

• Permanent hearing loss in the affected ear, which may affect speech discrimination and safety (e.g., inability to hear alarms).
• Tinnitus persistence – chronic ringing can be debilitating and associated with sleep disturbances.
• Psychosocial impact – isolation, reduced job performance, increased risk of depression.
• Balance disorders – chronic vertigo or disequilibrium, increasing fall risk especially in older adults.
• Underlying disease progression – if SSNHL is a manifestation of a tumor or autoimmune disorder, delayed diagnosis may allow disease advancement.

When to Seek Emergency Care

References

1. Mayo Clinic. “Sudden hearing loss.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/sudden-hearing-loss
2. Centers for Disease Control and Prevention. “Hearing Loss in Adults.” 2024. https://www.cdc.gov/ncbddd/hearingloss
3. National Institute on Deafness and Other Communication Disorders (NIDCD). “Sudden Sensorineural Hearing Loss Treatment.” 2022. https://www.nidcd.nih.gov/health/sudden-sensorineural-hearing-loss
4. JAMA Otolaryngology – Head & Neck Surgery. “Antiviral Therapy for Sudden Sensorineural Hearing Loss: A Systematic Review.” 2021.
5. Cochrane Database of Systematic Reviews. “Hyperbaric oxygen for sudden sensorineural hearing loss.” 2023.
6. World Health Organization. “WHO Guidelines for the Management of Sudden Deafness.” 2023.

```